PVOTF

 
Ordinary Shares SEC Reporting - Current
OTCQB
Verified Company Profile 9/25/2017
Contact Info
  • 1275 West 6th Avenue
  • Vancouver, BC V6H 1A6
  • Canada

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jul 31, 2017 10-Q
CIK 0001464165
Fiscal Year End 1/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: British Columbia, Canada
Year of Inc. 2002
Employees 2 a/o Sep 15, 2017
Company Officers/Contacts
Patrick Frankham CEO
Moira Ong CFO, Principal Acct. Officer
Stewart Muglich Securities Counsel
Company Directors
Ahmad Doroudian Chairman
Wolfgang Renz
Service Providers
Accounting/Auditing Firm
Sadler, Gibb & Associates, LLC
2455 E. Parleys Way
Suite 320
Salt Lake City, UT, 84109
United States
 
Securities Counsel
Alexander Holburn Beaudin + Lang LLP
2700-700 W Georgia Street
Vancouver, BC, V7Y 1B8
Canada
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Neurokine Pharmaceuticals Inc. until 4-2015
PVOTF Security Details
Share Structure
Market Value1 $38,793,760 a/o Oct 20, 2017
Authorized Shares 9,999,999,999 a/o Oct 16, 2017
Outstanding Shares 79,170,939 a/o Oct 16, 2017
-Restricted 38,818,565 a/o Oct 16, 2017
-Unrestricted 40,352,374 a/o Oct 16, 2017
Held at DTC 36,010,264 a/o Oct 16, 2017
Float 48,322,663 a/o Sep 15, 2017
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
ClearTrust, LLC
Shareholders
Shareholders of Record 59 a/o Sep 15, 2017
Short Selling Data
Short Interest 593 (139.11%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security